İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2014 · article

Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI

YÖKSİS OpenAlex
Yıl2014
Atıf42OpenAlex
Atıf43Semantic Scholar · 4 etkili
Yüzdelik%77,5
FWCI1,181,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q2

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıJOURNAL OF INHERITED METABOLIC DISEASE
  • Katalog eşleşmesi (ISSN)Journal of Inherited Metabolic Disease
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

OBJECTIVE: To assess oral manifestations of 17 patients with mucopolysaccharidosis type VI (MPS VI) or Maroteaux-Lamy syndrome. METHODS: We performed comprehensive oral examinations in 17 patients with MPS VI. Panoramic radiographs was performed only in 14 patients. All patients were of Thai, Turkish, and Indian origins. Ten of 17 patients had enzyme replacement therapy (ERT) (Naglazyme). Most Turkish patients (10/11) were on ERT. The Thai and Indian patients have never had ERT. RESULTS: Oral and radiographic examinations showed that hypoplastic mandibular condyles (93.3 %), malposition of unerupted teeth (92.9 %), large dental follicles (92.3 %), anterior open bite (86.7 %), maxillary constriction (56.3 %), and taurodontism (53.8 %) were common among patients with MPS VI. Newly recognized oral findings found in our study included taurodontism, long tooth roots, abnormal frenum, missing teeth, supernumerary teeth, and microdontia. Two patients who started ERT prior to 3 years old did not develope anterior open bite and one of them had mildly affected mandibular condyles. CONCLUSION: Our study provides the most comprehensive study of oral manifestations in patients with MPS VI. Receiving ERT at very young ages may lessen craniofacial malformations including hypoplasic mandibular condyles and anterior open bite. Oral manifestations can be used as diagnostic features for MPS VI prior to assessing leukocyte ARSB activity or urinary excretion of dermatan sulfate.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

42atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 12 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2018 Oral health status in patients with mucopolysaccharidosesAtıf 28 · OpenAlex
  2. 2018 Oral health status in patients with mucopolysaccharidosesAtıf 28 · OpenAlex
  3. 2018 Oral health status in patients with mucopolysaccharidosesAtıf 28 · OpenAlex
  4. 2018 Oral health status in patients with mucopolysaccharidosesAtıf 28 · OpenAlex
  5. 2018 Oral health status in patients with mucopolysaccharidosesAtıf 28 · OpenAlex
  6. 2014 Clinical manifestations of 17 patients affected with mucopolysaccharidosis type VI and eight novel ARSB mutationsAtıf 23 · OpenAlex
  7. 2014 Clinical manifestations of 17 patients affected with mucopolysaccharidosis type VI and eight novel ARSB mutationAtıf 23 · OpenAlex
  8. 2023 Çukurova Popülasyonunda Gelişimsel Diş Anomalisi Görülme Sıklığı: Radyografik Bir ÇalışmaAtıf 1 · OpenAlex
  9. 2023 Çukurova Popülasyonunda Gelişimsel Diş Anomalisi Görülme Sıklığı: Radyografik Bir ÇalışmaAtıf 1 · OpenAlex
  10. 2025 Orofacial manifestations in mucopolysaccharidoses: a comprehensive clinical and radiographic evaluation of 35 pediatric casesAtıf 0 · OpenAlex

Yazarlar

8
  1. PIRANIT NIK KANTAPUTRA 1
  2. HÜLYA KAYSERİLİ KARABEY 2
  3. YELİZ GÜVEN İSTANBUL ÜNİVERSİTESİ 3
  4. WARISSARA KANTAPUTRA 4
  5. MEHMET CİHAN BALCI İSTANBUL ÜNİVERSİTESİ 5
  6. PRANOOT TANPAIBOON 6
  7. ANUSHA UTTARILI 7
  8. ASHWIN DALAL 8